NCT04694053 is a clinical trial of surgical debridement in Fournier Gangrene, sponsored by University of Catania.

Who is sponsoring NCT04694053?

NCT04694053 is sponsored by University of Catania.

What drugs are being tested in NCT04694053?

Interventions in NCT04694053: surgical debridement.

What condition does NCT04694053 study?

NCT04694053 studies Fournier Gangrene.

Is NCT04694053 still recruiting?

NCT04694053 is currently completed. Last updated 5 January 2021.

Last reviewed 2021-01-05 · How we verify

NCT04694053

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fournier's Gangrene in Patient With Uncontrolled Type 2 Diabetes

Completed Last updated 5 January 2021

What this trial tests

trial testing surgical debridement in Fournier Gangrene in 1 participant. Completed in 1 December 2020.

Timeline

4 November 2020

Primary endpoint
10 November 2020

1 December 2020

Quick facts

Lead sponsor	University of Catania
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1
Start date	4 November 2020
Primary completion	10 November 2020
Estimated completion	1 December 2020
Sites	1 location across Italy

Drugs / interventions tested

surgical debridement

Conditions studied

Fournier Gangrene — all drugs for Fournier Gangrene →

Sponsor

University of Catania

Who can join

Eligibility, male only, with Fournier Gangrene. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A 66-year-old man, with a history of uncontrolled type 2 diabetes, obesity with BMI 38, chronic kidney failure and chronic heart failure, was admitted to the Emergency Department with a large area of necrosis involving the perineal and perianal regions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fournier's gangrene as a rare complication in patient with uncontrolled type 2 diabetes treated with surgical debridement: A case report and literature review.
Provenzano D, Lo Bianco S, Zanghì M, Campione A, et al · · 2021 · cited 7× · PMID 33757263 · DOI 10.1016/j.ijscr.2021.01.098

Verify or expand the search:

Other recruiting trials for Fournier Gangrene

Currently open trials in the same condition.

NCT07359651 — FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI). · recruiting

Other University of Catania trials

Trials by the same sponsor.

NCT07455643 — Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts · NA · completed
NCT06831487 — Analysis of Line-Field Confocal Optical Coherence Tomography (LC-OCT) in Characterization of Gingival Systemic Health, G · NA · enrolling by invitation
NCT06725095 — Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis · NA · enrolling by invitation
NCT06020937 — Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study · not yet recruiting
NCT07300657 — Impact of an AI-Based Chatbot on Implant Patient Management: RCT · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04694053 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Catania
Last refreshed: 5 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04694053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing